COVID-19 testing drives strong growth at Abbott

30 April 2021 - Deborah Wilkes

Premium

Abbott reported worldwide sales up by 32.9% on an organic basis to USD10.5 billion in the first quarter of 2021, driven by worldwide demand for COVID-19 testing. The company’s BinaxNOW COVID-19 Antigen Self Test is now available OTC in the US.

Click tags below for more information on topics:

Abbott COVID-19

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: